Literature DB >> 36114329

Knock-out of 5-lipoxygenase in overexpressing tumor cells-consequences on gene expression and cellular function.

Hannah Weisser1, Tamara Göbel1, G Melissa Krishnathas1, Marius Kreiß1, Carlo Angioni2, Duran Sürün3, Dominique Thomas2,4, Tobias Schmid5, Ann-Kathrin Häfner1, Astrid S Kahnt6.   

Abstract

5-Lipoxygenase (5-LO), the central enzyme in the biosynthesis of leukotrienes, is frequently expressed in human solid malignancies even though the enzyme is not present in the corresponding healthy tissues. There is little knowledge on the consequences of this expression for the tumor cells regarding gene expression and cellular function. We established a knockout (KO) of 5-LO in different cancer cell lines (HCT-116, HT-29, U-2 OS) and studied the consequences on global gene expression using next generation sequencing. Furthermore, cell viability, proliferation, migration and multicellular tumor spheroid (MCTS) formation were studied in these cells. Our results show that 5-LO influences the gene expression and cancer cell function in a cell type-dependent manner. The enzyme affected genes involved in cell adhesion, extracellular matrix formation, G protein signaling and cytoskeleton organization. Furthermore, absence of 5-LO elevated TGFβ2 expression in HCT-116 cells while MCP-1, fractalkine and platelet-derived growth factor expression was attenuated in U-2 OS cells suggesting that tumor cell-derived 5-LO shapes the tumor microenvironment. In line with the gene expression data, KO of 5-LO had an impact on cell proliferation, motility and MCTS formation. Interestingly, pharmacological inhibition of 5-LO only partly mimicked the KO suggesting that also noncanonical functions are involved.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 36114329     DOI: 10.1038/s41417-022-00531-9

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.854


  81 in total

1.  The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer.

Authors:  Christian K Nielsen; John F Ohd; Katarina Wikström; Ramin Massoumi; Sailaja Paruchuri; Maria Juhas; Anita Sjölander
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

Review 2.  Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease.

Authors:  Jesper Z Haeggström; Colin D Funk
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 3.  5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease.

Authors:  Olof Rådmark; Oliver Werz; Dieter Steinhilber; Bengt Samuelsson
Journal:  Biochim Biophys Acta       Date:  2014-08-22

4.  CaMKIIγ regulates the viability and self-renewal of acute myeloid leukaemia stem-like cells by the Alox5/NF-κB pathway.

Authors:  Jiang-Hua Cheng; Wen-Jing Zhang; Jun-Feng Zhu; Di Cui; Kai-Di Song; Ping Qiang; Chuan-Zhong Mei; Zheng-Chao Nie; Bang-Sheng Ding; Zhong Han; Zhi-En Ding; Wei-Wei Zheng
Journal:  Int J Lab Hematol       Date:  2020-12-25       Impact factor: 2.877

5.  PKC-β/Alox5 axis activation promotes Bcr-Abl-independent TKI-resistance in chronic myeloid leukemia.

Authors:  Dan Ma; Ping Liu; Ping Wang; Zhen Zhou; Qin Fang; Jishi Wang
Journal:  J Cell Physiol       Date:  2021-02-09       Impact factor: 6.384

6.  5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage.

Authors:  Valeria Barresi; Maddalena Grosso; Enrica Vitarelli; Giovanni Tuccari; Gaetano Barresi
Journal:  Dis Colon Rectum       Date:  2007-10       Impact factor: 4.585

7.  5-Lipoxygenase is a candidate target for therapeutic management of stem cell-like cells in acute myeloid leukemia.

Authors:  Jessica Roos; Claudia Oancea; Maria Heinssmann; Dilawar Khan; Hannelore Held; Astrid S Kahnt; Ricardo Capelo; Estel la Buscató; Ewgenij Proschak; Elena Puccetti; Dieter Steinhilber; Ingrid Fleming; Thorsten J Maier; Martin Ruthardt
Journal:  Cancer Res       Date:  2014-07-31       Impact factor: 12.701

8.  Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.

Authors:  Laleh G Melstrom; David J Bentrem; Mohammad R Salabat; Timothy J Kennedy; Xian-Zhong Ding; Matthew Strouch; Sambasiva M Rao; Richard C Witt; Charles A Ternent; Mark S Talamonti; Richard H Bell; Thomas A Adrian
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

9.  Overexpression of 5-lipoxygenase in sporadic colonic adenomas and a possible new aspect of colon carcinogenesis.

Authors:  Michał P Wasilewicz; Blanka Kołodziej; Teresa Bojułko; Mariusz Kaczmarczyk; Violetta Sulzyc-Bielicka; Dariusz Bielicki; Katarzyna Ciepiela
Journal:  Int J Colorectal Dis       Date:  2010-06-12       Impact factor: 2.571

10.  Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia.

Authors:  Yaoyu Chen; Yiguo Hu; Haojian Zhang; Cong Peng; Shaoguang Li
Journal:  Nat Genet       Date:  2009-06-07       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.